Skip to main content
Log in

Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 04 May 2017

Abstract

Hyaluronic acid (HA) is involved in modulating inflammatory airway processes and mucociliary clearance. Some studies have tested the effectiveness of the topical administration of HA in patients with upper airway diseases with positive preliminary results. A prospective, single-blind, 1:1 randomised controlled study was performed to assess the efficacy and safety of the daily topical administration of 9 mg of sodium hyaluronate in 3 mL of a 0.9 % sodium saline solution on the basis of endoscopic and clinical parameters in children with chronic adenoiditis associated with recurrent acute otitis media and otitis media with effusion; age- and gender-matched children receiving normal 0.9 % sodium chloride saline solution were used as controls. Analysis was based on 103 (mean age 63.3 ± 18.2 months; 52 males, 50.5 %) children: 54 in the study group and 49 in the control group. A statistically significant reduction in the mean number of all acute otitis media episodes (AOME) (mean reduction 0.8 ± 0.4 per month; p value 0.05) and AOME without tympanic membrane perforation (mean reduction 0.6 ± 0.3 per month; p value 0.04) after recruitment was documented only in the study group. HA significantly improved all the endoscopic outcomes (p values ranging between 0.05 and <0.01) but one. Nasal washing with saline solution was effective on only three of them (p values ranging between 0.03 and <0.01). No untoward effects were documented. Our results confirm the safety and document the positive effect of topically administered HA solution on children with chronic adenoiditis associated with middle ear disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Baraniuk JN, Shizari T, Sabol M et al (1996) Hyaluronan is exocytosed from serous, but not mucous cells, of human nasal and tracheobronchial submucosal glands. J Investig Med 44:47–52

    CAS  PubMed  Google Scholar 

  2. Mullol J, Chowdhury BA, White MV et al (1993) Endothelin in human nasal mucosa. Am J Resp Cell Mol Biol 8:393–402

    Article  CAS  Google Scholar 

  3. Partsch G, Schwarzer C, Neumüller J et al (1989) Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid. Z Rheumatol 8:123–128

    Google Scholar 

  4. Krasinski R, Tchorzewski H (2007) Hyaluronan-mediated regulation of inflammation. Postepy Hig Med Dosw 61:683–689 (online)

    Google Scholar 

  5. Gelardi M, Guglielmi AV, De Candia N et al (2013) Effect of sodium hyaluronate on mucociliary clearance after functional endoscopic sinus surgery. Eur Ann Allergy Clin Immunol 45:103–108

    CAS  PubMed  Google Scholar 

  6. Manzanares D, Monzon ME, Savani RC et al (2007) Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON. Am J Resp Cell Mol Biol 37:160–168

    Article  CAS  Google Scholar 

  7. Kawabata S, Kuwata H, Nakagawa I et al (1999) Capsular hyaluronic acid of group A streptococci hampers their invasion into human pharyngeal epithelial cells. Microb Pathog 27:71–80

    Article  CAS  PubMed  Google Scholar 

  8. Cywes C, Stamenkovic I, Wessels MR (2000) CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest 106:995–1002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Drago L, Cappelletti L, De Vecchi E et al (2014) Antiadhesive and antibiofilm activity of hyaluronic acid against bacteria responsible for respiratory tract infections. Acta Pathol Microbiol Immunol 122:1013–1019

    Article  CAS  Google Scholar 

  10. Castelnuovo P, Tajana G, Terranova P et al (2015) From modeling to remodeling of upper airways: centrality of hyaluronan (hyaluronic acid). Int J Immunopathol Pharmacol 21:160–167

    Google Scholar 

  11. Macchi A, Terranova P, Digilio E et al (2013) Hyaluronan plus saline nasal washes in the treatment of rhino-sinusal symptoms in patients undergoing functional endoscopic sinus surgery for rhino-sinusal remodeling. Int J Immunopathol Pharmacol 26:137–145

    Article  CAS  PubMed  Google Scholar 

  12. Macchi A, Castelnuovo P, Terranova P et al (2013) Effects of sodium hyaluronate in children with recurrent upper respiratory tract infections: results of a randomised controlled study. Int Immunopathol Pharmacol 26:127–135

    Article  CAS  Google Scholar 

  13. Gelardi M, Iannuzzi L, Quaranta N (2013) Intranasal sodium hyaluronate on the nasal cytology of patients with allergic and nonallergic rhinitis. Int Forum Allergy Rhinol 3:807–813

    Article  PubMed  Google Scholar 

  14. Varricchio A, Capasso M, Avvisati F et al (2014) Inhaled hyaluronic acid as ancillary treatment in children with bacterial acute rhinopharyngitis. J Biol Regul Homeost Agents 28:537–543

    CAS  PubMed  Google Scholar 

  15. Gates GA, Klein JO, Lim DJ et al (2002) Recent advances in otitis media. 1. Definitions, terminology, and classification of otitis media. Ann Otol Rhinol Laryngol Supp 188:8–18

    Google Scholar 

  16. American Academy of Family Physicians, American Academy of Otolaryngology—Head and Neck Surgery and American Academy of Pediatrics Subcommittee on Otitis Media With Effusion (2004) Otitis media with effusion. Pediatrics 113:1412–1429

    Article  Google Scholar 

  17. Cassano P, Gelardi M, Cassano M et al (2003) Adenoid tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings: a novel approach to therapeutic management. Int J Pediatr Otorhinolaryngol 67:1303–1309

    Article  PubMed  Google Scholar 

  18. Marseglia GL, Poddighe D, Caimmi D et al (2009) Role of adenoids and adenoiditis in children with allergy and otitis media. Curr Allergy Asthma Rep 9:460–464

    Article  PubMed  Google Scholar 

  19. Torretta S, Marchisio P, Cappadona M et al (2013) Nasopharyngeal fiberendoscopy in children: a diagnostic challenge in current clinical practice: how we do it. Int J Pediatr Otorhinolaryngol 77:747–751

    Article  PubMed  Google Scholar 

  20. Browning GG, Rovers MM, Williamson I et al (2010) Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 6:CD001801

    Google Scholar 

  21. Rovers MM, Black N, Browning GG et al (2005) Grommets in otitis media with effusion: an individual patient data meta-analysis. Arch Dis Child 90:480–485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Petrigni G, Allegra L (2006) Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pulm Pharmacol Ther 19:166–171

    Article  CAS  PubMed  Google Scholar 

  23. Venge P, Pedersen B, Håkansson L et al (1996) Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. Am J Respir Crit Care Med 153:312–316

    Article  CAS  PubMed  Google Scholar 

  24. Jang CH, Cho YB, Choi CH et al (2013) Effect of anti-adhesion barrier solution containing ciprofloxacin-hydrocortisone on abraded mucosa with otitis media. Int J Pediatr Otorhinolaryngol 77:19–24

    Article  PubMed  Google Scholar 

  25. Marchisio P, Picca M, Torretta S et al (2014) Nasal saline irrigation in preschool children: a survey of attitudes and prescribing habits of primary care pediatricians working in northern Italy. Ital J Pediatr 5:47

    Article  Google Scholar 

  26. Marchisio P, Varricchio A, Baggi E et al (2012) Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. Int J Immunopathol Pharmacol 25:721–730

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Air Liquide Medical Systems Italy S.p.A. for the supply of the micronised nasal douche (Rhinowash) used in this study and Dr. Carla Pascariello for her role in children assessment.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Torretta.

Ethics declarations

Financial disclosure

This study was sponsored by IBSA Farmaceutici Italia Srl.

Conflict of interest

Authors do not have any financial relationship with the organization that sponsored the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Torretta, S., Marchisio, P., Rinaldi, V. et al. Endoscopic and clinical benefits of hyaluronic acid in children with chronic adenoiditis and middle ear disease. Eur Arch Otorhinolaryngol 274, 1423–1429 (2017). https://doi.org/10.1007/s00405-016-4327-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-016-4327-4

Keywords

Navigation